Insider · CIK 0001419187

Skyline Venture Partners V LP

Reports to the SEC for 6 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001419187

Forms 4 and 5

Insider transactions

47 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-01-27	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−1M sh	$21.50	−$21.5M	2,819,985
2019-08-26	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−152K sh	$18.40	−$2.81M	3,819,985
2019-08-23	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−180 sh	$20.03	−$3,605.4	3,972,409
2019-08-22	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−2,185 sh	$20.05	−$43.8K	3,972,589
2019-08-21	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−27.1K sh	$20.14	−$545K	3,992,918
2019-08-21	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−18.1K sh	$20.17	−$366K	3,974,774
2019-08-12	SIBNSI-BONE, Inc.S Sale	10% Owner	SSale	−400K sh	$18.25	−$7.3M	4,019,985
2018-10-19	SIBNSI-BONE, Inc.C Conversion	10% Owner	CConversion	+2.21M sh	—	—	2,213,425
2018-10-19	SIBNSI-BONE, Inc.C Conversion	10% Owner	CConversion	+792K sh	—	—	3,005,620
2018-10-19	SIBNSI-BONE, Inc.C Conversion	10% Owner	CConversion	+691K sh	—	—	3,696,309
2018-10-19	SIBNSI-BONE, Inc.C Conversion	10% Owner	CConversion	+399K sh	—	—	4,094,985
2018-10-19	SIBNSI-BONE, Inc.P Purchase	10% Owner	PPurchase	+325K sh	$15.00	+$4.88M	4,419,985
2018-10-19	SIBNSI-BONE, Inc. · Warrant (right to buy)X Exercise of In-Money	10% Owner	XExercise of In-Money	−39.4K sh	—	—	0
2018-10-19	SIBNSI-BONE, Inc. · Series 5 Preferred StockX Exercise of In-Money	10% Owner	XExercise of In-Money	+39.4K sh	—	—	816,099
2018-10-19	SIBNSI-BONE, Inc. · Series 5 Preferred StockS Sale	10% Owner	SSale	−23.9K sh	$14.00	−$335K	792,195
2018-10-19	SIBNSI-BONE, Inc. · Series 4 Preferred StockC Conversion	10% Owner	CConversion	−2.21M sh	—	—	0
2018-10-19	SIBNSI-BONE, Inc. · Series 5 Preferred StockC Conversion	10% Owner	CConversion	−792K sh	—	—	0
2018-10-19	SIBNSI-BONE, Inc. · Series 6 Preferred StockC Conversion	10% Owner	CConversion	−652K sh	—	—	0
2018-10-19	SIBNSI-BONE, Inc. · Series 7 Preferred StockC Conversion	10% Owner	CConversion	−399K sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	10% Owner	CConversion	+926K sh	—	—	925,578
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	10% Owner	CConversion	+520K sh	—	—	1,445,842
2018-10-01	STROSUTRO BIOPHARMA, INC.C Conversion	10% Owner	CConversion	+514K sh	—	—	1,960,053
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series C Preferred StockC Conversion	10% Owner	CConversion	−25M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series D Preferred StockC Conversion	10% Owner	CConversion	−12.8M sh	—	—	0
2018-10-01	STROSUTRO BIOPHARMA, INC. · Series E Preferred StockC Conversion	10% Owner	CConversion	−18.7M sh	—	—	0
2017-12-05	COLLCOLLEGIUM PHARMACEUTICAL, INCJ Other	10% Owner	JOther	−800K sh	—	—	2,149,916
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INCC Conversion	10% Owner	CConversion	+1.55M sh	—	—	1,552,795
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INCC Conversion	10% Owner	CConversion	+382K sh	—	—	1,935,118
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INCC Conversion	10% Owner	CConversion	+865K sh	—	—	2,799,916
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INCP Purchase	10% Owner	PPurchase	+150K sh	$12.00	+$1.8M	2,949,916
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INC · Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−10.7M sh	—	—	0
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INC · Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.64M sh	—	—	0
2015-05-12	COLLCOLLEGIUM PHARMACEUTICAL, INC · Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−5.88M sh	—	—	0
2015-02-20	Dicerna Pharmaceuticals IncS Sale	former 10% holder	SSale	−37.5K sh	$26.02	−$977K	1,719,671
2014-02-04	Dicerna Pharmaceuticals IncC Conversion	former 10% holder	CConversion	+312K sh	—	—	312,000
2014-02-04	Dicerna Pharmaceuticals IncC Conversion	former 10% holder	CConversion	+179K sh	—	—	491,322
2014-02-04	Dicerna Pharmaceuticals IncC Conversion	former 10% holder	CConversion	+1.04M sh	—	—	1,534,751
2014-02-04	Dicerna Pharmaceuticals IncP Purchase	former 10% holder	PPurchase	+200K sh	$15.00	+$3M	1,734,751
2014-02-04	Dicerna Pharmaceuticals IncSeries A Preferred StockC Conversion	former 10% holder	CConversion	−312K sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion	former 10% holder	CConversion	−179K sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion	former 10% holder	CConversion	−1.04M sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncCommon Stock WarrantC Conversion	former 10% holder	CConversion	+755 sh	—	—	755
2014-02-04	Dicerna Pharmaceuticals IncSeries C Preferred Stock WarrantsC Conversion	former 10% holder	CConversion	−21.7K sh	—	—	0
2014-02-04	Dicerna Pharmaceuticals IncCommon Stock Warrant (right to buy)C Conversion	former 10% holder	CConversion	+21.7K sh	—	—	21,697
2011-11-15	MAKO Surgical Corp.J Other	10% Owner	JOther	−500K sh	—	—	2,245,249
2011-05-09	MAKO Surgical Corp.J Other	10% Owner	JOther	−1.05M sh	—	—	2,745,249
2009-08-14	MAKO Surgical Corp.P Purchase	10% Owner	PPurchase	+758K sh	$7.25	+$5.5M	3,195,249

Recent filings

Accepted (ET)
Aug 144
Skyline Venture Management V, LLC0001562180-20-005448
SEC(opens sec.gov)
Aug 274
Skyline Venture Partners V LP0001562180-19-004501
SEC(opens sec.gov)
Aug 234
Skyline Venture Partners V LP0001562180-19-004461
SEC(opens sec.gov)
Aug 144
Skyline Venture Partners V LP0001562180-19-004290
SEC(opens sec.gov)
Oct 194
Skyline Venture Partners V LP0001209191-18-055698
SEC(opens sec.gov)
Oct 34
Skyline Venture Partners V LP0001104659-18-060241
SEC(opens sec.gov)

Companies

Address

525 UNIVERSITY AVE.

PALO ALTO, CA, 94301